(Rachel Orr/The Washington Post)
This story has been updated.
Mallinckrodt Pharmaceuticals company has agreed to pay $100 million to settle a lawsuit alleging that a company it acquired in 2014 engaged in anti-competitive behavior to preserve its monopoly on a $34,000-a-vial infantile...
Read full post here:
https://skpsoft.com/business/maker-of-34000-a-vial-drug-to-pay-100-million-for-allegedly-preventing-competition/
Wednesday, January 18, 2017
Maker of $34,000-a-vial drug to pay $100 million for allegedly preventing competition
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment